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Chapter
Introduction
The term ’managed care’ can be defined as health care systems that integrate
the financing and delivery of appropriate and comprehensive health care services to
covered individuals through arrangements with selected providers (Einsure, Accessed
February 18, 2005). Managed care plans differ from traditional health plans or indemnity
"fee for service" health insurance plans which were the type of plans that existed before
the rise of managed care organizations. The main differences are the costs structure
and that indemnity plans allow more freedom of choice for patients and physicians.
Patients can choose the physicians they prefer to see and physicians can order
whatever services they feel are necessary. With indemnity plans, the individual pays a
pre-determined percentage of the cost of health care services, and the insurance
company (or self-insured employer) pays the other percentage. For example, an
individual might pay 20 percent for services and the insurance company pays 80
percent. The fees for services are defined by the providers and vary from physician to
physician. Indemnity health plans usually restrict such services as preventive medicine
office visits, immunizations and other screening tests that can be costly to members
when they are financially responsible for the services that are not covered by these
types of health plans.
The differences in the costs in the various plans may be significant. The US
Department of Labor reported that in 1999-2000, total out-of-pocket medical spending
was significantly higher, on average, for consumers with fee-for-service insurance
($2,315 per year) than for consumer units covered by a health maintenance organization
($1,789) (Monthly Labor Review, 2003).
There are three basic types of managed care plans: (1) Health Maintenance
Organizations (HMOs), (2) Preferred Provider Organizations (PPOs), and (3) Point of
Service (POS) plans. There are both similarities and differences between the types of
plans. All managed care plans involve an arrangement between the insurer and a
selected network of health care providers (doctors, hospitals, etc.). All offer policyholders
significant financial incentives to use the providers in that network. There are usually
specific standards for selecting providers and formal steps to ensure that quality care is
delivered.
HMOs provide medical treatment on a prepaid basis, which means that HMO
members pay a fixed monthly fee, regardless of how much medical care is needed in a
given month. In return for this fee, most HMOs provide a wide variety of medical
services, from preventive care and office visits to hospitalization and surgery. With a few
exceptions, HMO members must receive their medical treatment from physicians and
facilities within the HMO network.
A PPO is composed of doctors and/or hospitals that provide medical service to a
specific group or association only. Rather than prepaying for medical care, PPO
members pay for services as they are rendered. The PPO sponsor (usually an employer
or insurance company) generally reimburses the member for the cost of the treatment,
less any co-payment. In some cases, the physician may submit the bill directly to the
insurance company for payment. The insurer then pays the covered amount directly to
the healthcare provider, and the member pays his or her co-payment amount. The price
for each type of service is negotiated in advance between the healthcare providers and
the PPO sponsor(s).
A POS plan is a type of managed healthcare system where the member pays no
deductible and usually only a minimal co-payment when a healthcare provider within the
network is used. The member must also choose a primary care physician who is
responsible for all referrals to other providers within the POS network. If the member
chooses to go outside of the network for healthcare, then a deductible and substantial
co-payment is incurred.
In addition to network strategies and financial incentives, HMOs also manage
health care services as part of cost containment. The management of health care
services in a HMOs usually involves three key components: oversight of the medical
care given; contractual relationships and organization of the providers giving care; and
the covered benefits tied to managed care charter. It is structured around a variety of
incentives to encourage the practice of cost-effective medicine, to minimize variation in
clinical practice patterns and to positively impact the quality of care. Explicit standards
for selection of health care providers, formal programs for ongoing quality assurance and
utilization review, and significant financial incentives for members to use providers and
procedures associated with the plan are also part of the managed care system. For
example, clinical practice guidelines are often used as an educational tool to improve
quality, reduce variability of care, reduce costs, and reduce risk and liability (Wallak
1991).
Managed care entities have utilization management (UM) processes that involve
the coordination of how much or how long care is given for each patient as well as the
level at which the care is delivered. The goal is to ensure care is delivered cost-
effectively, at the right level, and without the use of unnecessary resources. Most UM
programs focus on cost containment by reducing the number of inpatient hospital
admissions and eliminating unnecessary hospital days. Typically, nurses are utilized to
review hospital admission for medical necessity prior to the admission (pre-certification)
and determine the need for ongoing care (concurrent review). Common characteristics
of these programs are the review of medical records to collect data on the symptoms,
diagnoses, test results and the plan of treatment of the individual. The information is
then compared to medical necessity criteria. If the criteria are not met, the case is
referred to a medical director. The medical director reviews the medical information
provided and applies the medical necessity criteria as well as his or her medical
expertise, then renders a decision for admission or continued hospitalization. If the
admission or continued hospitalization is medically appropriate, additional reviews are
periodically scheduled. If the admission or continued stay is denied, the attending
physician is consulted and a plan is mutually agreed upon, which may result in discharge
of the patient. The physician and member have the right to appeal the decision if they
disagree.
Health Net of the Northeast (HNNE)is a managed care organization with 1.1
million members in Connecticut, New York and New Jersey. In January of 2002, the
Connecticut division of the HNNE Medical Management team held a series of internal
meetings to develop cost effective strategies for the utilization management process at
HNNE. One of the considerations was to evaluate high volume admission diagnoses to
determine if there were opportunities for cost savings without compromising quality of
care and promoting favorable patient outcomes.
Analysis of hospital claims admission diagnoses for HNNE in 2000 and 2001
indicated that community-acquired pneumonia (CAP) consistently appeared as one of
the ten most frequently occurring diagnoses for members 18 years and older
hospitalized in Connecticut. CAP is. an acute infection of the pulmonary parenchyma that
can include symptoms of acute infection accompanied by the presences of an acute
infiltrate on a chest x-ray or by auscultatory findings such as altered breath sounds
and/or local rales. Additionally, fever or hyperthermia, rigors, sweating, new cough with
or without sputum production or changes in the color of respiratory secretions, chest
discomfort, or the onset of dyspnea may be present. Nonspecific symptoms may also
occur and include fatigue, myalgias, abdominal pain, anorexia and headache (Bartlett
2000). CAP is associated with varying degrees of severity ranging from mild symptoms
to respiratory failure and death.
It is estimated that CAP affects three to four million Americans annually at a cost
of nine billion dollars. It has a significant impact on medical care utilization with an
estimated 10 million physician visits per year, between 500,000 to 600,000
hospitalizations and 45,000 deaths in the US (Fine et al 1997). In 1996, it was the 6
most common cause of death among hospital discharges (Hospital Discharge Statistics
1996). The mortality rate had been found to range from 2% to 30% among hospitalized
individuals, the average being at approximately 14%. The incidence of hospitalization is
estimated to be 258 cases per 100,000 of the population; among those 65 years or older
the hospitalization rate is 962 per 100,000. The cost for inpatient therapy is estimated at
as much as 20 times that of outpatient therapy. For patients aged 65 and greater, the
average length of stay is projected to be 7.8 days with an average cost at $7166 per
patient. Under the age of 65, the average length of stay is 5.8 days at an average cost at
$6042 per patient. Most of the overall charges are related to facility bed and board costs
and intravenous antibiotic costs (Fine et al 2000). In contrast, the outpatient costs
associated with an episode of CAP ranges from $200 thru $500, including physician
office visits, laboratory and radiology services and antibiotic therapy (Lave et al 1999).
HNNE utilization management (UM) staff were interested in identifying members
with CAP who could potentially be treated on an outpatient basis, providing an
opportunity to reduce admissions and bed days without compromising patient care. Over
the two-year period from 2000-2001, 1526 HNNE members were admitted with CAP.
Trend analysis of the data for members admitted with pneumonia for two years (Table 1)
indicates a 13% increase in admissions and a 12% increase in bed days from 2000 and
2001, though the average length of stay had decreased slightly by one quarter of a day.
Because of the increasing number of bed days and admissions associated with this
diagnosis, the utilization management team at HNNE questioned if there was an
opportunity to evaluate whether members with CAP were appropriately being admitted to
acute care institutions or if care be provided in an alternate setting with no adverse
outcomes to the patient. They estimated that if 20% or 305 patients who had an
approximate length of stay of three days were not admitted and treated in an outpatient
setting, 915 bed days would have been saved. At an average per diem bed day cost of
$1600, the two-year savings from deferring hospitalization would be approximately $1.5
million, excluding the costs of outpatient care.
Chapter II
Literature Review
In the early 1990’s, the Agency of Health Care Policy and Research (AHCPR)
provided grants for several studies on the quality and cost effectiveness of current
therapies for treating some of the most common and costly medical conditions in the
United States. One of the grants funded the Pneumonia Patient Outcomes Research
Team (PORT), a five-year multi-centered project to study the quality and cost
effectiveness of current therapies for the treatment for CAP. The study found that there
was considerable variation in hospital admission rates for CAP from one geographic
region to another and that the rates were not directly related to local disease severity.
This suggested that clinicians were using inconsistent criteria when making the initial
decision about the appropriate site of care. They theorized that physician uncertainty in
assessing the severity of illness at presentation and the tendency to overestimate the
patient’s risk of short-term mortality caused unnecessary admissions. Patients with a
physician-estimated risk of death in excess of 5 percent were 18 times more likely to be
hospitalized. Because of the lack of evidence-based admission criteria and risk
stratification information, the researchers hypothesized that many low risk patients who
could be treated safely on an outpatient basis were being admitted to the hospital for
inpatient care (Fine et al 1997).
The PORT researchers concluded that accurate, objective models of prognosis
for CAP could help physicians assess patient’s risks and improve the decisions about
hospitalization. Their goal was to develop a prediction rule for prognosis that would
accurately identify patients with CAP who are at low risk of dying within 30 days of
presentation and to assess the predictive accuracy of this rule for clinically relevant major
outcomes. By determining the severity of illness and identifying objective criteria to risk
stratify patients with CAP, this rule could assist clinicians in determining the most
appropriate site of service for newly diagnosed cases of CAP (Fine et al 1997).
The prediction rule for prognosis was developed by analyzing hospital data from
14,199 adult inpatients with CAP discharged from 78 hospitals in 23 states. In the study,
the patients with the following characteristics were excluded: 18 years of age or younger,
patients who were HIV positive, patients who had been hospitalized previously within
seven days prior to the current admission or patients who had been transferred from
another acute care hospital. Medical records were abstracted to collect data on more
than 250 key clinical findings including demographics, history, physical examination,
coexisting illnesses, laboratory and radiographic findings.
From this data, the researchers developed the Pneumonia Severity Index (PSI),
in which patients in a two step process based in weighted risk factors, can stratified into
five severity classes. The data elements for the PSI are shown in Figure 1. In the first
step, an initial history and physical examination are performed. The patient’s risk level is
evaluated using factors such as age, gender, presence of other illnesses, and abnormal
physical examination findings. Patients are asked whether they have a history of
neoplastic disease, congestive heart failure, cerebrovascular disease, renal disease, or
liver disease. The physician then determines whether the patient has any of the
following" altered mental status, a pulse rate greater than or equal to 125 beats per
minute, a respiratory rate greater than or equal to 30 breaths per minute, systolic blood
pressure less than 90 mm Hg, and temperature less than 35 C or greater than or equal
to 40 C. Patients are assigned to the lowest risk class (I) based on the scoring 50 or
below) of this initial history and physical examination.
For patients not assigned to the lowest risk class, the second step is based on
diagnostic tests that are used to further determine risk of death or other adverse
outcomes. Blood tests determine the extent and effects of pneumonia by measuring
blood levels of sodium, glucose, and blood urea nitrogen as well as arterial pH
(acidity/alkalinity balance) and the hematocrit. Additionally, a chest x-ray is obtained to
determine how whether or not a pleural effusion is present.
On the basis of these results, patients are placed in a risk category ranging from
II to V. Point assignments correspond with the following classes: Class II with a score of
51- 70, Class III with a score between 71 to 90, Class IV with a score between 91 to 130
and Class V with a score >130.
The PSI was independently validated using a statewide database with 38,039
adult CAP patients discharged from 193 general hospitals. In the validation study,
mortality was found to be low for risk classes I-III (0.1% to 2.8%), intermediate for class
IV (8.2% to 9.3%), and high for class V (27% to 29.2%). Risk class was also positively
associated with subsequent hospitalization and delayed return to usual activities for
outpatients and with increased rates of admission to the ICU and length of stay for
inpatients. On the basis of these observations, Classes I, II and III were considered to be
low risk and Class IV and V were considered to be high risk. The Pneumonia PORT
investigators concluded that patients in risk classes or II generally are candidates for
outpatient treatment, risk class III patients are potential candidates for outpatient
treatment or brief inpatient observation, and patients in classes IV and V should be
hospitalized (Fine et al 1997). They suggested that if the PSI was utilized, between 26%
and 31% of patients admitted to hospitals could safely be treated in an alternate setting
and an additional 13% 19% could be briefly admitted for observation with no negative
effect on patient outcomes. Potential savings is estimated to be between $457 and $994
per patient per year (Fine et al 1997).
The variability in treatment strategies for CAP has been found to have
implications for health care costs and the application of PSI could have an impact on the
costs attributed to patient care without sacrificing quality. Several studies in the medical
literature describe how the PSI was utilized to enhance the decision for site of care
treatment for CAP. Lave et al (1999) published a study on the cost of treating CAP. The
data used in the study was obtained from six different sources: the Pennsylvania (PA)
MediQual Pneumonia Database, the PA Medicare Pneumonia Sample, the Pneumonia
PORT Cohort Study Data, the National Health Interview Survey (NHIS), the National
Hospital Discharge Survey and the Hospital Cost Utilization Project. The study found
considerable variation in how CAP was managed across the United States as reflected
in variations in hospital admission rates, hospital lengths of stay and the costs of treating
a case. The total costs associated with treating CAP in the United States were estimated
as $10 billion in 1994. In that year, the estimated cost of an episode of care was $300
(range of $264 to $421) for outpatients and $5,700 (range of $4,260 to $7,545) for
inpatients including hospital charges, physician care and follow-up care. The study also
found that patients with similar presentations were treated differently in hospital
admissions, length of hospitalization and antimicrobial use. The average length of stay
across states, a major cost contributor, was 4.6 days with a average cost of $1800 per
day. The median cost of antibiotic therapy for an inpatient episode was $228.70, ranging
across four hospitals studied from $183.67 to $315.60 for similarly ill patients with similar
outcomes (Lave et al 1999).
The researchers noted that there was a considerable amount of data suggesting
that hospital admission for most patients is discretionary. Data from the PA MediQual
pneumonia database showed that a substantial number of inpatients had a low PSI
score at presentation. Of the 36,222 patients in the database, 37.6% were classified as
low risk with a predicted probability of dying of less than 4%. The results are similar to
the analyses from the pneumonia PORT cohort study, in which a substantial number of
inpatients had similar presentations to patients who were treated as outpatients. No
differences were found in clinical outcomes in both of these groups (Lave et al 1999).
Lave et al (1999) suggested four major strategies for modifying the treatment of
pneumonia that would have a significant impact on reducing costs and maintaining
quality of care. These strategies include" the identification of low risk patients currently
being treated as inpatients who could safely be treated in the outpatient setting;
decreasing length of stay; minimizing the use of the emergency department as the site
for initial evaluation; and promoting the use of lower cost antibiotics.
Fine et al (1997) published the findings of a multi-center controlled trial with the
objective to assess the effectiveness and safety of using the PSI for the initial site-of-
treatment decision. In this trial, 19 emergency departments were randomly assigned
either to continue conventional management of CAP or to implement a critical pathway
that included the PSI to guide the admission decision. Emergency room physicians were
educated about the rule and were encouraged to treat those in risk Classes I-III as
outpatients with oral antibiotics. Overall, 1,743 patients with CAP were enrolled in this
six-month study. Use of the PSI resulted in an 18% reduction in the admission of low-risk
patients and did not result in an increase in mortality or morbidity or compromise
patient’s 30-day functional status. This study supported the use of the PSI to assist
physicians in identifying low-risk patients who can be safely treated in outpatient settings
(Fine et al 1997).
Marras et al (2000) studied the validity of the PSI in estimating mortality, to
determine its utility in decision-making regarding hospitalization, and to assess factors
influencing this decision. The retrospective study of patient medical records took place in
Canada in 1996. The study population was comprised of a consecutive cohort of adults
with CAP, excluding patients affected by HIV, tuberculosis or otherwise
immunosuppressed. Specially trained nurses collected the data using the PSI tool and
stratified patients into the five PSI risk categories. Of the 244 patients enrolled in the
study, 29% were identified as low risk. When comparing the characteristics of the study
population to the initial Pneumonia PORT cohort, the cohorts were similar in most
respects. In Canada study population, however, the proportion of nursing home patients
was nearly fourfold higher and 31% had an altered mental status at presentation. The
Canadian cohort also tended to be sicker with a higher proportion of patients in risk
Classes IV and V. The researchers concluded that the PSI predicted mortality very well
and was able to stratify risk categories. However, the authors cautioned against using
the PSI as a sole decision tool because it did not consider psychosocial factors that were
found to be important elements in the decision for admission, such as homelessness,
substance abuse, or inadequate home supports. The role of the PSI in making the
admission decision should be a component in the algorithm, along with considerations,
all of which need careful assessment in this process (Marras et al 2000).
The American College of Emergency Physicians (ACEP) (2001) published a
guideline to assist emergency physicians in the management of CAP in the emergency
department (ED). The guideline, based on a review of the medical literature available at
that time and expert consensus, summarized the currently available information in the
risk assessment, disposition and treatment of CAP in the ED, including key clinical
information needed to determine the severity of CAP for risk stratification to determine
whether a patient could be treated as an outpatient or inpatient. The ACEP
recommended the use of the PSI in the risk classification of patients but limitations to the
PSI were noted, such as the presence of additional medical conditions (e.g.
immunosuppression) that were not included in the tool and psychosocial
contraindications to outpatient care. They concluded that the PSI was valid as a mortality
prediction rule and but should not be used as a sole method for triage of patients with
CAP (ACEP 2001).
Goss et al (2003) reported on a prospective cohort study of the cost and
incidence of social co-morbidities in low risk patients with CAP admitted to a public
hospital in Washington state in 1994 through 1996. The purpose of the study was to
evaluate the clinical characteristics, cost of care and resource utilization of patients with
low-risk CAP in an urban public hospital serving an indigent population. After excluding
members aged less than 18 and those with HIV seropositivity, 253 patients remained.
Application of the PSI identified 55% in the low-risk Classes I- III who could have
potentially been treated on an outpatient basis. However, of the 138 patients who were
low risk according to the PSI, 49% had a history of alcoholism, 20% had a blood alcohol
level greater than 50 mg/dl, and 44% were homeless, all which would preclude patients
from unsupervised outpatient treatment. Though the use of the PSI accurately predicted
which patients would be at low risk for death, the utility of using the PSI by itself to
reduce low risk CAP hospital admissions in an indigent population with high rates of
homelessness, substance abuse and medical needs were not captured in the PSI
(Goss et al 2003).
Aliyu et al (2003) evaluated the variability in decision-making in managing CAP
with respect to the initial site of care (inpatient versus outpatient). The study addressed
demographic, social and financial factors in addition to clinical factors in an attempt to
evaluate their significance in decisions involving hospital admissions of low-risk CAP
patients. A retrospective analysis of 296 low risk CAP patients evaluated within a one
year period at a hospital in Maryland was conducted. Patients were stratified into
Classes I-V according to PSi. Two hundred eight (70%) were evaluated and discharged
from the emergency department to complete outpatient antibiotic therapy, while 88
(30%) were hospitalized. A comparison of demographic, clinical, social and financial
parameters was made between the ED discharged and hospitalized groups. High fever,
tachycardia, female gender, African-American race and medical insurance coverage
were identified as determinants for hospitalization among low risk CAP patients. There
were no statistically significant differences between the hospitalized group and ED
discharged group for altered mental status, hypotension, tachypnea,
laboratory/radiological parameters and there were no differences in mortality or
treatment failure between the two groups. The researchers did find that several factors
that the PSI did not take into account influenced the decision to admit a patient. The
most important factors were poor social support, inability to maintain oral intake and
history of substance abuse. They also determined that the admission decision might also
be influenced by the availability of outpatient support services (home nursing, home
intravenous therapy) and alternative sites for care such as sub-acute care services
(Aliyu et al 2003).
Arnold et al (2003) published a study comparing the PSI to the clinical judgment
of physicians in determining the site of care for treating CAP. The objectives were to
define clinical factors that could justify hospital admission among patients with CAP low
risk Classes or II, and to determine the value of the PSI as the sole indicator for
detecting inappropriate hospitalizations among patients with CAP. The study population
consisted of consecutive adult patients fulfilling the criteria for CAP who were admitted to
two hospitals in Kentucky between 1997 and 2000. Risk stratification was made by
review of the medical records of patients with CAP. Those identified with having a risk
class of or II were further reviewed retrospectively to determine whether there was a
clinical basis to justify hospitalization. Of a total of 328 patients, 26% (86) had a risk
Class of or I1. Among these, 72 (86%) had clinical factors that justified their hospital
admission. These factors, in frequency of occurrence, included the following: 46% with
medical conditions other than CAP that required hospitalization, 43% had social needs,
18% had oral intolerance, 14% experienced failure of outpatient therapy, 14% were
noncompliant, 9% had suspicion of sepsis and 1% had hypoxemia. Among the 86
patients with low risk Classes (i.e., Classes or II), 14 were found to be inappropriately
hospitalized, yielding a positive predictive value of 16% (Arnold et al 2003). The
researchers concluded that the PSI should not be used as the sole indicator for
detecting inappropriate hospitalizations because it does not take into account the
severity of comorbid conditions requiring in-hospital care in patients with a non-severe
pneumonia (Arnold et al 2003).
Campbell et al (2004) evaluated the PSi as a tool to assess the safety of
discharging patients from the ED with CAP. Study methodology included a systematic
retrospective review of medical records of 867 adult patients with CAP discharged from
an emergency department in 1993. Readmission or death rates within 30 days of
discharge were evaluated, using data from all local hospitals and from the provincial
coroner. Results of the study showed that 79% of the patients discharged from the ED
had PSI scores of 90 or less. Approximately 2% were admitted to the hospital and
0.76% died within 30 days of the ED visit. Thirty-day readmission and death rates for
patients with low risk CAP patients compared to the high risk were 7.14% and 9.34%
respectively. The researcher concluded that adult patients with CAP discharged from the
ED who were identified as low risk according to the PSI score had low readmission and
death rates, and were generally safely managed as outpatients (Campbell et al 2004).
In each of the studies that applied the PSI, the researchers did agree that the PSI
is an excellent risk stratification tool. However, it was not recommended as a sole
method to determine the site of treatment and that it is meant to contribute to rather than
to supersede a physician’s judgment. Other factors need to be considered in determining
whether an individual patient is a candidate for outpatient care. Patients designated as
low risk may have additional medical and psychosocial contraindications to outpatient
care, including compliance problems with medical treatment or poor social support at
home. Ability to maintain oral intake, history of substance abuse, cognitive impairment
and concomitant illnesses are not included as predictors in the PSI but increase the
likelihood of a poor prognosis, therefore precluding outpatient treatment.
Because of success of the PSI in risk stratifying patients with CAP, the HNNE
management team was interested in incorporating it into the UM process that was
currently in place. The medical necessity criteria that is used in HNNE’s utilization review
process is from InterQual, which is commonly used in the managed care industry.
InterQual’s Intensity of Service, Severity of Illness and Discharge Screen (ISD) criteria
are used to guide decision-making to determine the appropriateness of admissions,
continued services, and discharge across the continuum of care. The ISD criteria uses
clinical indicators to determine the proper level of care, based on the patient’s severity of
illness and service requirements. It is applied to the entire continuum of care, ensuring
that care is provided in the appropriate setting. One of the limitations of the ISD criteria
is that there is no ability to derive a risk score to identify patients at low risk; therefore,
the PSI was of interest to Health Net.
The investigator evaluated the PSI and compared it to the ISD data currently
being collected during the utilization review process (Table 2). The criteria were similar,
but the current process did not apply the weighted risk factor scoring system as with the
PSI. The perceived benefit of the scoring system is to eliminate subjectivity and
quantitatively identify members with low risk scores who potentially could be candidates
for outpatient treatment. The patients identified as low risk would be reviewed by a
HNNE medical director to determine if the hospital admission was appropriate or if
outpatient treatment could have been attempted. Results of the medical director review
would be analyzed. This proposal was presented to the members of the medical
management team for consideration. The response was positive and it was felt that the
results could prove a valuable assessment of the characteristics of the pneumonia
patients admitted for in hospital treatment.
Chapter III
Research Objectives and Purpose
The overall objective of this study was to test the application of the PSI in the
HNNE population and its utility for utilization management functions of the HMO. The
specific research questions were:
What percentage of patients hospitalized with a diagnosis of CAP could be
classified into low risk and might be appropriate for outpatient treatment?
Were any patient or system factors associated with the PSI score?
Was the PSI predictive of length of stay?
What factors other than the PSI score may account for hospitalization?
Was the PSI a feasible and useful tool for assessing appropriateness of
hospitalization or as part of the UM process?
The results of this study were intended to assist HNNE in understanding the
characteristics of members who are admitted for CAP and identify those who may be
appropriately treated in a less acute care setting. It also may provide objective points of
discussion for HMO medical directors and physicians who consistently admit low risk
CAP patients and provide an opportunity for physician education.
Chapter IV
Methodology
This study was a pilot to apply the PSI during HNNE’s UM process, replacing the
IDS criteria that are currently being used. HNNE’s UM process is fairly standard within
the industry. Within 24 hours of a hospital admission of a HNNE member, the admitting
hospital notifies the HNNE Utilization Management (UM) Department of the admission.
The HNNE UM nurses are then responsible for medical record review, either by
telephone or by an actual site visit. The medical record is reviewed and specific clinical
data are abstracted. The data are then compared to the InterQual criteria to determine
the need for admission and length of stay. Patients who do not meet the criteria are
referred to a medical director to determine if the admission is appropriate and to contact
the admitting physician if it is not.
In order to obtain complete information, this study was implemented only for
medical records that were actually reviewed on site rather than by telephone. Concurrent
chart review was conducted on 133 consecutive HNNE members admitted to 32
Connecticut hospitals in 2002. Members included those with a primary diagnosis of
pneumonia based on the International Classification of Diseases, Ninth Revision (ICD-9)
codes for pneumonia (481-486). Patients under 18 years of age, those admitted to ICU
for respiratory failure requiring ventilator support, or those having a diagnosis of
aspiration pneumonia were excluded. To maintain confidentiality, no patient identifying
information was gathered. Data collection began in June 2002 and continued until 133
consecutive HNNE member records were evaluated using the PSI. Data collection
ended in November 2002.
Data abstracted from medical charts included the PSI elements and their
corresponding point assignment used to derive a risk score as shown in Figure 1. A risk
score (total point score) for a given patient was obtained by summing the patient age in
years (age -10 for females) and the points for each applicable patient characteristic.
Other demographic variables not included in the PSI were collected including: hospital
and provider identification number, physician specialty, length of stay, admission source
and discharge disposition. Because of the studies in the literature review where it was
noted that the PSI should not be used as the sole determinate for the admission
decision, the HNNE team suggested that any issues not found in the PSI that would
preclude outpatient treatment also be collected. One of the medical directors had an
interest in determining if antibiotics were being prescribed appropriately and suggested
that organism causing the pneumonia and the antibiotic used for treatment be included.
The data collection tool, entitled Community-Acquired Pneumonia Review
Project, (Appendix A) was developed with ease of use and data analyses in mind. In
order to minimize the amount of text collected and keep the form brief, short answers
and check boxes were used wherever possible to allow the form to be completed quickly
and accurately. Scoring points for each element were clearly delineated to facilitate
calculation of the PSI score. A note to remind the nurse that a score of 90 or below
required review by a HNNE medical director was incorporated into the form.
With the assistance of the Senior Medical Director and the Director of the
Utilization Management Department, an introduction to the study was carefully planned
to ensure that the staff had an understanding the expectations and the study
requirements. The investigator conducted training for the 18 UM nurses and 5 medical
directors using a Power Point presentation (Appendix B) that included an explanation of
the goals and objectives of the study, how to apply the scoring system, and the process
to follow when a medical director review was warranted. The nurses who were actually
using the scoring document were given additional in-service training at the beginning of
the study and periodically through out the data collection period to maintain quality
control and fidelity.
Data Collection Process
The UM nurses reviewed the medical record of any patient admitted to an acute
care hospital with the diagnosis of CAP.
2. The nurse applied the HN CAP Review Project Tool to determine the risk level of
the patient and completed the data collection abstraction form contained in
Appendix A.
3. Patients with a risk score of 90 or less (PSI Class to Iii) were discussed with a
HNNE Medical Director to determine the appropriateness of the admission. If the
medical director concluded that the admission was appropriate, the reason for
the decision was documented on the form. If the admission was questionable,
the medical director contacted the attending physician for discussion of
alternatives to hospitalization.
4. Upon completion, the data sheet was sent to the investigator who performed
quality control by identifying any missing or questionable information. If this
occurred, the UM nurse was contacted for the appropriate information and the
form corrected if possible.
5. Once the form was corrected, the data were entered into an Excel spreadsheet,
then into SPSS for further data analysis.
A total number of 133 patient records were reviewed. Thirty-three were discarded
because of lack of complete data (10), incorrect primary diagnosis (10), patients who
met the exclusion criteria (5) or because the PSI score was miscalculated (8) resulting in
a patient being assigned into a high risk category rather than low risk. In the 8 cases
where the score was tabulated incorrectly, the medical records were no longer available
for review and a medical director review could not be obtained. Miscalculation of the risk
score occurred early in the data collection phase and improved after the nurses became
more familiar with the data collection tool.
Frequency distributions were used to examine the correspondence between the
entire population of HNNE patients 18 years of age or older admitted to Connecticut
hospitals with CAP in 2002 and the study population of 100 members. The purpose of
this analysis was to determine if the study population was a representative sample of the
CAP patients that were hospitalized in 2002. Additionally, the relative frequency
distributions were compared to identify differences between the low and high-risk
patients according to the PSI score. The differences were analyzed by Chi-Square Tests
or T- tests to determine statistical significance.
Chapter V
Findings
The demographic characteristics of the study population can be found in Table 2.
Of the 100 CAP patients, the mean age was 69 years and there were an equal
distribution between men and women. The mean length of stay was 5.37 days. The
majority of patients (65%) were treated in larger hospitals (i.e. 500 beds or more) by
Internal Medicine physicians (94%). The majority of the patients were admitted from the
Emergency Department (78%) and discharged home (74%). Twenty two percent were
admitted from a nursing home and 23% of the study population was also discharged to a
nursing home.
The risk factors of the study population used to derive the risk score are found in
Table 3 and consist of comorbid diseases, physician examination and laboratory
findings. The two most prevalent comorbid conditions were cerebrovascular disease
(CVD) at 33% and congestive heart failure (CHF) at 27%. The most common physical
finding was altered mental status (21%) with the remaining physician examination
findings such as elevated respiratory rate and pulse were between 11% and 7%. The
laboratory findings indicated that 31% had an elevated blood urea nitrogen (BUN). The
remaining laboratory findings were between 15% (PO2 <60 mmHg) and 4% (pH < 7.35).
Table 3 also contains information regarding the causative organism and antibiotic usage.
For the majority of patients (92%), no organism was identified. The most commonly
prescribed antibiotics were intravenous Rocephin and Zithromycin. Sixty-eight percent
were prescribed two antibiotics.
Table 4 describes the risk score distribution of the PSI categories of the study
population. An analysis of the risk class of the CAP cases revealed that the PSI scores
ranged between 26 and 195. Sixty-two patients were classified as high risk (Class IV or
V) and 38 at low risk (Class I, II or III). Men tended to have a higher risk score than
women with 109.5 being the average risk score for the men was 109.5 and 93.5 for the
women.
In order to determine if the 100 patients included in the CAP study population
were a representative sample of the entire population, a comparison was made of the
demographic characteristics of the study group and all the other CAP patients
hospitalized in 2002 (Table 2). In addition to the 100 patients in the study group, 791
HNNE members aged 18 years or older with CAP were admitted to hospitals in
Connecticut. Information that was available from claims data were examined for the
remaining 791 CAP patients. There were no differences between the study population
and the overall population with respect to the average age of the patients (69 years), the
gender distribution and average length of stay (5.36 days vs 5.19 days respectively).
Sixty five percent of the study population was admitted to hospitals with 500 or more
beds compared to 59% of the other CAP group. Additionally, there were no differences
in the discharge disposition where 74% of the study population was discharged home,
23% to nursing homes compared to 77% of the other CAP population was discharged
home and 23% were discharged to nursing homes.
There were, however, statistically significant differences in the specialties of the
admitting physician and the source of admission between the overall CAP population
and the study population. Internal Medicine specialists admitted 94% of the study
population while only 80% of the overall population was admitted by this specialty (p <=
.01). For 6% of the overall population, no physician specialty was listed. Seventy eight
percent of the study population was admitted through the Emergency Department,
compared to 59% of all the other CAP patients (p < .001). Sixteen percent of the larger
population was admitted from other sources such as other institutions or directly from the
physician’s office. Six percent of the overall population had no source of admission
listed. One factor that may explain the variation between the two groups is that the data
from the overall population was obtained from claims data as opposed to the data that
was collected directly from the medical records of the study group of CAP patients. This
would result in more complete information for the study group because it was manually
extracted from their medical records.
Of the 100 patients in the study population, 38% were scored as low risk
patients, while 62% were identified as high risk. When comparing the low and high risk
groups there were statistically significant differences in the mean risk scores of 66 and
128 (p < .001) and the mean age of 58.5 and 77.5 (p < .001) as seen in Table 5.
Additionally, none of the patients in the low risk group were admitted from nursing
homes compared to 29% in the high-risk group (p < .001).
The high-risk patients had an average of 1.44 comorbid conditions in contrast
.53 (p < .001)in the low risk group. One comorbid condition that appeared statistically
more frequently in the high risk groups was CVD (p < .025). For physical exam findings,
altered mental status was noted in 32% of the high-risk patients and none of the low risk
group (p < .001). Elevated respiratory rate occurred more frequently in the high-risk
group in 16% but in less than 1% of the low risk group (p <. 01). The only statistically
different laboratory value between the low and high risk groups was related to an
elevated BUN, which occurred in 48% of the high risk group in contrast to only 11% of
the low risk group (p < .001).
There were no differences between the low and high risk groups with respect to
the comorbid conditions of neoplastic disease (16% vs 25%), liver disease (2% vs 3%),
and renal disease (2% vs 5%). Similar physical findings occurred between the low and
high risk groups for the elevated systolic BP (3% vs 4%, respectively), elevated
temperature (4% vs 6% respectively) and elevated pulse (5% vs 6% respectively).
Similarities also occurred in the remaining laboratory findings, including low pH (1% vs
3%), low sodium (2% vs 5%), decreased Hematocrit (1% vs 5%), decreased PO2 (1% vs
20%), elevated glucose (1% vs 16%) and the presence of pleural effusions (1% vs 17%).
No organisms were identified in the majority of both high and low risk group and there
were no difference in the specialty of the admitting physician as internal medicine
specialists admitted the vast majority in both groups.
When comparing the low and high risk groups, there was a statistically
significant difference in the average length of stay (5.15 vs 5.58) (t[98] =-.644, p= .521).
An unexpected finding was the lack of a linear relationship between PSI score and
average length of stay, where the length of stay for classes III and IV were shorter than
Class 1 and II (Figure 3). However, when a scatterpiot (Figure 4) was utilized to
visualize the risk Class and the length of stay of the individual study members, the
correlation between the two variables is more evident.
All of the 38 cases identified by the PSI as low risk were submitted to the HNNE
medical directors for review of the medical appropriateness of the admission. The results
of this review can be found in Table 6. All but one of these admissions was approved for
inpatient treatment. The reasons for approval were categorized into the following groups:
34% had concomitant illness, 18% had severe symptoms, 18% were initially treated on
an outpatient basis but the patient did not experience an improvement in the pneumonia,
13% of patients required intravenous steroids, 7% were unable to take oral medications,
and 2% had mental or social issues that precluded outpatient treatment. Only one
patient with a risk score of 40 was identified as inappropriately admitted. That patient
was discharged after a 2-day length of stay.
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Summary and Discussion
The PSI tool was relatively easy to use once the UM nurses became more
familiar with it. The two most common reasons that accounted for the excluded 33
records in the study population were: patients who met the exclusion criteria being under
18 years of age and those cases in which CAP was not the primary diagnosis for
admission but rather a secondary diagnosis. Placing the exclusion criteria on the tool
itself may have eliminated this problem. Periodic in-services with all the nurses and
medical directors may also been beneficial to share experiences with the tool and any
data collection issues.
Since the majority of patients were admitted by physicians specializing in
Internal Medicine, analysis could not be performed to detect any specialty related
differences. However, it may be a factor in a larger study population since there was a
statistically significant difference in the admitting specialty types when comparing the
overall population to the study population (94% vs 80% p < .01).
Patients in the low risk group were younger by an average of 19 years, had one
less comorbid condition and half day shorter length of stay than the high-risk group.
Several risk factors occurred more frequently in the high-risk population; elevated BUN,
cerebrovascular disease, altered mental status, low P02 and elevated glucose.
Congestive heart failure consistently occurred in both groups at 25% and 26%. Because
the number of and complexity of the comorbid conditions and other risk factors have a
direct influence on the risk score, these findings are not unexpected. More high risk
patients were admitted to larger hospitals and admitted from and discharged to nursing
homes than the low risk group.
The PSI risk stratification distribution in the study group was similar to the study
results published in the literature. Between 30-39% of CAP members as reported in the
various studies were risk stratified into the low risk category and between 61% and 70%
were in the high risk class. In addition, the literature reported that the common reasons
for admission of the low risk members were attributed to factors such as severe
symptoms at presentation and failed attempts at outpatient treatment. The HNNE
medical director reviews yielded similar results as the predominating factors in the
decision to admit patients with CAP (Table 6). The literature also identified social issues
such as homelessness, alcohol and other drug misuse as factors precluding outpatient
treatment, but this factor did not appear to be an issue in this study population. One
explanation is that in the other studies, patients were identified by diagnosis regardless
of insurance status and indigent populations were included. This study included only
members with health insurance.
The PSI tool itself did assist HN medical management in determining that the
majority (99%) of patients are appropriately admitted to hospitals for treatment of CAP.
In all but one case (1%), the medical directors felt that the admissions were justified.
However, the medical directors were made aware of the objectives of the study, the PSI
criteria and participated in the implementation process. If the reviews were blinded and
independently performed, results may have been different.
When the study results are applied to the entire CAP population, 38% (342) of
the approximately 900 patients admitted with CAP would be identified as low risk. If the
one percent of the approximately 900 patients were considered as being appropriate for
outpatient treatment, only 9 patients may not require admission, if each patient had a
LOS of 5 days, 45 bed days could be eliminated. With the average hospital day cost of
$1,800, the approximate savings per year would equal $81,000. The approximate cost
of outpatient treatment of an episode of CAP is $400 (Lave et al 1999). Subtracting the
cost of treating 9 patients with CAP ($3,600) from the hospital cost $81,000 would
recognize an approximate annual savings of $77,400. But this may be a conservative
estimate of the potential cost savings. With a 95% confidence interval of .03% 5.45%, 5
patients could potentially not have been admitted which would yield a saving of
approximately $385,000.
There were several limitations to this study, including the small sample size and
the potential subjectivity of the medical director reviews. The study also did not take into
account the outcomes for patients with CAP who were seen in the ED and discharged
home for outpatient treatment. Additionally, it is not known if the ISD criteria would have
identified the same patients that potentially could have been treated on an outpatient
basis. The study took place from June to November 2002. CAP is a disease that is
usually more prevalent in the winter months. If the study was initiated in that time of
year, the study cohort may have had different characteristics and PSI scores, which may
have influence the study results. The HNNE management team reviewed the results of
this study and concluded that it provided a new perspective on the UM review process
and was helpful in identifying that the CAP patients admitted to the hospital were not
candidates for outpatient treatment and why. However, the UM nurses did spend more
time completing the tool and calculating the score for each case than they would have if
using the traditional UM criteria. The nurses also noted that they would have not
submitted as many cases for medical director review because they would have made the
decision to approve the admission on their own, but were bound by the 90 or below
threshold for medical director review, in summary, the team decided to consider the
most conservative result and determined that the relatively insignificant potential annual
savings of $77,000 and the additional time and effort involved in using the PSI, there
was no advantage over the traditional UM process at HNNE.
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Table 1
TABLES
Two year trend in members over 18 years of age admitted with
CAP
Bed Days
Mean LOS
# of Admits
2000 2001
4393 4934
6.25 days
715
6 days
811
Table 2 Characteristics of the Study Population Compared to all CAP
Admissions in 2002
Mean Age
Gender
Female
Male
Mean Length of Stay
Hospital Size
<500 beds
500 + beds
Admitting Physician Specialty
Internal Medicine
Other
Unknown
Source of Admission
Emergency Department
Nursing Home
= Other
Unknown
Discharge Disposition
Home
= Nursing Home
Transfer to Other Institution
Expired
Unknown
All CAP
n = 791
69
52%
48%
Study
Population
69
5O%
5O%
n =100
5.19 5.36
41%
59%
8O%
13%
6%
59%
18%
16%
6%
35%
65%
94%
6%
O%
78%
22%
O%
O%
74%
23%
2%
1%
O%
77%
17%
3%
2%
1%
Statistical
Significance
*p < .01
*p < .001
Table 3 Risk Factors in the Study Population
Risk Factor
Comorbid diseases
Neoplastic disease
Liver disease
Congestive heart failure
Cerebrovascular disease
Renal disease
Physical examination findings
Altered mental status
Respiratory rate 30/minute or more
Systolic blood pressure <90 mmHg
Percent
16%
5%
27%
33%
7%
21%
11%
7%
Temperature <35 degrees C or 40 degrees C or more
Pulse 125/minute or more
Laboratory findings
pH <7.35
BUN >10.7 mmol/L
Sodium <130 mEq/L
Glucose >13.9 mmol/L
Hematocrit <30 percent
PO <60 mmHg
Pleural effusion
Causative Organism
None Identified
Antibiotics
10%
11%
Single
Two
4%
31%
7%
12%
6%
15%
14%
94%
36%
64%
Table 4 PSI Risk Classes of CAP Patients
Risk Score Number Percent Cumulative Class
Class Percent
Class <= 50 :3 :3% 3% Low Risk
Class II 51 -70 18 18% 21% 38
Class III 71-90 17 17% 38%
Class IV 91-130 31 31% 69% High Risk
Class V >130 31 31% 100% 62
Table 5 Comparison of High and Low Risk Groups
Characteristics
Mean Risk Score
PSI Class
Low Risk
(n = 38)
66
High Risk (n
= 62)
128
Mean LOS 5.15 5.58 days
Gender
Male
Female
Mean Age
Mean number of comorbid conditions
From Nursing Home
Comorbid Conditions
Neoplastic Disease
Liver Disease
CHF
CVD
Renal Disease
Physical Exam Findings
Altered Mental Status
Resp Rate 30/minutes or more
Systolic BP< 90 mmHg
Temp < 35 or>40 degrees C
Pulse 125/minute or more
Laboratory Findings
pH < 7.35
BUN > 10.7mmol/L
Sodium < 130mEq/L
Glucose > 13.9 mmol/L
Hematocrit < 30 percent
PO2 <60mmHg
Pleural Effusion
Organism Identified
Yes
No
Admitting Physician Specialty
Internal Medicine
Other
Hospital Size
* 500+
< 500
Source of Admission
42%
58%
58.5
.53
0%
16%
2%
26%
18%
2%
O%
<1%
3%
4%
5%
1%
11%
2%
1%
1%
1%
1%
7%
93%
99%
1%
39%
61%
92%
8%
84%
10%
3%
3%
Emergency Department
Nursing Home
Discharge Disposition
Home
Nursing Home
Transferred to Other Institution
Expired
55%
45%
77.5
1.44
29%
25%
3%
25%
43%
5%
32%
16%
4%
6%
6%
3%
48%
5%
16%
5%
20%
17%
5%
95%
92%
8%
66%
34%
70%
30%
68%
30%
2%
0%
Stat Significance
*p < .001
*p = .521
*p _< .001
*p < .001
*p < .001
*p _< .025
*p < .001
*p _< .01
*p _< .001
*p < .001
*p _< .01
*p _<.01
*p _< .025
Table 6 Results of Medical Director Review of Low Risk CAP Patients
Reason
Concomitant Illness
Severe Symptoms
Outpatient Treatment Failed
IV Steroids
Number
13
Percent
34%
18%
18%
13%
Cant take oral medication 3 8%
Mental/Social Issues 2 5%
Admission not appropriate
Total:
2%
38 99%
Figure I Scoring System for Pneumonia Severity Index (PSI)
iPatient..Ch,aracteristic P0ints Assigned ’!t
Demographic factors
Age" Males
Age" Females
i!.Nusi..n.g..h0me....resident
Comorbid diseases
Neoplastic disease
Liver disease
Congestive heart failure
Age (in years)
Age (in years)-10
+20
Cerebrovascular disease
Renal disease +10
Physical examination findings
Altered mental status +20
Respiratory rate 30/minute or more +20
Systolic blood pressure <90 mmHg +20
+15Temperature <35 degrees C or 40 degrees C or more
Pulse 125/minute or more +10
Laboratory findings
pH <7.35
BUN >10.7 mmol/L
Sodium <130 mEq/L
Glucose >13.9 mmol/L
Hematocrit <30 percent
+30
+20
+20
i+10
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Appendix A Community-Acquired Pneumonia Review Project Data Collection Tool
Health Net Community-Acquired Pneumonia Review Project
Study Number
Hospital
Provider Name Spec"
Date of Admission
Date of Discharge
Disposition
LOS
UM Nurse Initials Date
Organism Identified Y or N
Pneumonia Severity Risk Score
Stratification of Risk Score
Risk/Risk Class
Low/I
Low/II
Low/III
Moderate/IV
High/V
Based on
Algorithm
</= 70 points
71-90 points
91-130 points
> 130 points
Source of
Admission
ER or Direct
Physician Reason
for Admission
Antibiotics Route (POor
v)
Total Risk Score of 90
or
Less is an Automatic
Medical Director
Review
Patient Characteristics Points
Male
Females
Nursing Home Resident
If no I--I Rehab Facility !--I Home
Neoplastic Disease
Liver Disease
CHF
Cerebrovascular Disease
Renal Disease
Altered Mental Status
Respiratory Rate >/= 30 per minute
Systolic BP < 90
Temperature <97 deqrees or > 104 degrees
Pulse >/= 125 min
Ph < 7.35
BUN > 10.7mm/L (> 25mg/dl)
Sodium <130 mmq/L
Glucose > 13.9 mmol/L (> 200 mq/dl)
Hematocrit < 30%
P02 < 60 mmHq
Pleural Effusion
TOTAL
Age in Years
Age 10
Add +10
r-i Yes (+30) r-I No
r-] Yes (+20) I-I No
I--I Yes (+10) [-] No
r-I Yes (+10) r-] No
r-] Yes (+10) I--I No
r] Yes (+20) I’-I No
I-I Yes (+20) FI No
r-] Yes (+20) I--I No
I--I Yes (+ 15) I-] No
I--I Yes (+ 10) I No
I-’I Yes (+30) l No
[-] Yes (+20) I-’] No
r] Yes (+20) [] No
I-I Yes (+20) F-I No
I--1 Yes (+10) No
r-] Yes (+1o) r] No
r] Yes (+1o) l-I No
I--] Not Done
I--I Not Done
I--] Not Done
[--I Not Done
I--I Not Done
I--] Not Done
Appendix B Presentation
Community Acquired Pneumonia
Review Project
Jean Sandstrom
UM Team Presentation
Start Date: April 10, 2002
Community Acquired Pneumonia (CAP)
.Facts
Sixth most common infectious disease in the US
Leading cause of death of infectious etiology
Usually bacterial characterized by inflammation of the lungs,
productive cough, change in sputum consistency, may or may not
have radiological evidence, decreased breath sounds or rales
Acute symptoms differ depending on etiology and virulence of
infecting pathogen and general condition of the host
Atypical CAPs usually milder, non purulent form with nonproductive
cough usually caused by Mycoplasrna, Chlamydia and Legionella,
Utilization and Cost for CAP
Annual US costs between 4 6 billion dollars- majority associated
with hospitalized patients
Inpatient therapy costs as much as 20 times that of outpatient
Patients over 65 have an average LOS of 7.8 days at a cost of
$7200
Patients less than 65 have an average LOS of 5.8 days at a cost of
$6000
Most of the cost is related to facility and IV antibiotic costs
Health Net Utilization
Commercial Bed Days
Avg LOS
# of Admits
Medicare Bed Days
Avg LOS
# of Admits
Medicaid Bed Days
Avg LOS
# of Admits
1999 2000 2001
1526 1604 1867
5.45 4.6 5.3
337 345 353
2816 2789 3067
6.6 7.3 6.7
356 370 458
613 729 561
4.37 3.8 3.5
149 192 155
Pneumonia Severity Index
AHCPR funded study/ PORTs
Clinical prediction model
Risk stratification
Most appropriate site for treating CAP
Considers comorbid conditions, age, gender, physical
condition, ancillary tests
Tested on > 50,000 CAP patients in 275 hospitals
26 31% admissions could have been treated as outpatients
13 19% could have had shorter stays
Criteria Comparison
Pneumonia Svrit Index
Ae. Gender, Nursin(i Home Resident
CA, Liver Dx, CHF, CVD .nal Dx
Altered mental status
Req:)irtory rote >l: 30 I::w.r minute
Stolic BP 90
Temp 97 or 104
Pul >/: 125/rain
Ph 7.35
BUN 10.7 mm/L
Sodium, 130 mem/L
Gluco 13.9 mmeVL
Hcnatocrit
PO2
.60 mm
Pleural Effusion
Not included
Not included
Not included
Current Intepal Critia
Ae 75,NursiRl Home Resident
Comorbid Condition
Altered mental status
Respiratory rate >/: 30 per minute
Systolic BP 90
Temp> 104
Heart rte 120/min
Not included
Not included
Not included
Not included
Hematocrit 25
02 aturation 91% PO2 60 mmH
Pulmonary Infiltrate
WBC Abnormality
Positiv sputum culture
Failed outmtit treatmt
Health Net Savings in CT
In 1999 1354 total bed days saved with associated savings of
$2.16 million
In 2000 1425 bed days saved with associated savings of $2.28
million
In 2001 1585 total bed days saved with associated savings of
$2.5 million
calculated for all product lines at an average hospital per diem of
$600)
Study Objectives
Can the PSI-
Identify potential unnecessary admissions
Provide value added from current UM admission criteria
Identify factors associated with low risk scores
Provide actionable data for the medical directors
Methodology
Population:
Patients over the age of 18 admitted with diagnosis of
pneumonia
Exclude admissions to intensive care, patients with aspiration
pneumonia, ventilator dependent
On site review hospitals only
March 1st May 30tl admissions
Process (DOCUMENt!)
Admission medical record review using data collection tool
Calculate score to determine risk stratification
If score is 90 or less refer to Medical Director
Medical Director approves admission or contacts attending MD
Document reason for admission (clinical and non-clinical)
Send completed material to Jean Sandstrom
Outcome Analysis
Percent of patients within PSI risk stratification
Characteristics of each risk class
Length of stay and issues related to extended LOS
Medical Director review results of low risk population
Is this a useful tool for UM
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